Investigation of the vasorelaxant effects of 3-(5′-hydroxymethyl- 2′-furyl)-1 -benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 5, 2007, Pages 521-526

  Berkan, Ocal ^a   Bagcivan, Ihsan ^a   Kaya, Tijen ^a   Yildirim, Kemal ^a   Yildirim, Sahin ^a   Doǧan, Kasim ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

cGMP; DEA NO; Radial artery; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; DIETHYLAMINE; IBERIOTOXIN; NITRIC OXIDE; PHENYLEPHRINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIAL ARTERY; VASOCONSTRICTION; VASODILATATION;

AGED; ANALYSIS OF VARIANCE; CORONARY ARTERY BYPASS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATORS; ENZYME INHIBITORS; FEMALE; HUMANS; HYDRAZINES; INDAZOLES; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; OXADIAZOLES; PEPTIDES; PHENYLEPHRINE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; QUINOXALINES; RADIAL ARTERY; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 34548169099     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-033     Document Type: Article

References (18)

1. Acar, C., Jebara, V.A., Portoghese, M., Beyssen, B., Pagny, J.Y., Grare, P., et al. 1992. Revival of the radial artery for coronary-artery bypass-grafting. Ann. Thorac. Surg. 54: 652-660.
2. Carpentier, A., Guermonprez, J.L., Deloche, A., Frechette, C., and DuBost, C. 1973. The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann. Thorac. Surg. 16: 111-121.
3. Cetin, A., Kaya, T., Demirkoprulu, N., Karadas, B., Duran, B., and Cetin, M. 2004. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium. J. Pharmacol. Sci. 94: 19-24. doi:10.1254/jphs.94.19.
4. Conant, A.R., Shackcloth, M.J., Oo, A.Y., Chester, M.R., Simpson, A.W.M., and Dihmis, W.C. 2003. Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: The effect of other vasodilators. J. Thorac. Cardiovasc. Surg. 126: 448-454. doi:10.1016/S0022-5223(03)00388-X.
5. Friebe, A., and Koesling, D. 1998. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53: 123-127.
6. He, G.W. 2001. Arterial grafts for coronary surgery: vasospasm and patency rate. J. Thorac. Cardiovasc. Surg. 121: 431-433. doi:10.1067/mtc.2001.113593.
7. He, G.W., and Yang, C.Q. 1999. Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro. Br. J. Clin. Pharmacol. 48: 99-104. doi:10.1046/j.1365-2125.1999.00969.x.
8. Hsieh, G.C., O'Neill, A.B., Moreland, R.B., Sullivan, J.P., and Brioni, J.D. 2003. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats. Eur. J. Pharmacol. 458: 183-189. doi:10.1016/S0014-2999(02)02730-9.
9. Johns, R.A. 1991. Endothelium-derived relaxing factor: basic review and clinical implications. J. Cardiothorac. Vasc. Anesth. 5: 69-79. doi:10.1016/1053-0770(91)90099-F.
10. Koesling, D., and Friebe, A. 1999. Soluble guanylyl cyclase: structure and regulation. Rev. Physiol. Biochem. Pharmacol. 135: 41-65.
11. Lee, Y.C., Martin, E., and Murad, F. 2000. Human recombinant soluble guanylyl cyclase: expression, purification and regulation. Proc. Natl. Acad. Sci. U.S.A. 97: 10763-10768. doi:10.1073/pnas.190333697.
12. Morley, D., and Keefer, L.K. 1993. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol. 22: S3-S9.
13. Mullershausen, F., Russwurm, M., Friebe, A., and Koesling, D. 2004. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272. Circulation, 109: 1711-1713. doi:10.1161/01.CIR.0000126286.47618.BD.
14. Nakane, M., Hsieh, G.C., Miller, L.N., Chang, R., Terranova, M.A., Moreland, R.B., Kolasa, T., and Brioni, J.D. 2002. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. Int. J. Impot. Res. 14: 121-127. doi:10.1038/sj.ijir.3900843.
15. Rosenfeldt, F.L., He, G.W., Buxton, B.F., and Angus, J.A. 1999. Pharmacology of coronary artery bypass grafts. Ann. Thorac. Surg. 67: 878-888. doi:10.1016/S0003-4975(98)01299-5.
16. Salom, J.B., Barbera, M.D., Centeno, J.M., Orti, M., Torregrosa, G., and Alborch, E. 1999. Comparative relaxant effects of the NO donors sodium nitroprusside, DEA/NO and SPER/NO in rabbit carotid arteries. Gen. Pharmacol. 32: 75-79. doi:10.1016/S0306-3623(98)00087-1.
17. Schmidt, K., Schrammel, A., Koesling, D., and Mayer, B. 2001. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells. Mol. Pharmacol. 59: 220-224.
18. Vanhoutte, P.M. 1989. Endothelium and control of vascular function. State of the Art lecture. Hypertension, 13: 658-667.